Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 63Cardiovascular Diseases 3Neoplasms 2Stage II Prostate Adenocarcinoma 1Sarcopenia 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Metabolic Syndrome 1Metabolic Diseases 1Eunuchism 1Diabetes Mellitus 1Dementia 1Cognitive Dysfunction 1Advanced Prostate Cancer 1

Interventions

Zoledronic Acid 5bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Cholecalciferol 2Calcium 2Absorptiometry, Photon 2Vitamin D 1Toremifene 1Risedronic Acid 1Radiotherapy 1Lysine Acetyltransferase 5 1Gonadotropin-Releasing Hormone 1Estrogen Antagonists 1Estradiol 1Denosumab 1Calcium Gluconate 1Calcium Carbonate 1Blood Specimen Collection 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Gonadotropin-Releasing Hormone × Genitourinary × Clear all
NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
109 enrolled 8 charts
Genitourinary

Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡